Islam Al-Khawaldeh
Dr Christine Basmadjian
Dr Cinzia Bordoni
Dr Suzannah Harnor
Amy Heptinstall
et al. | An alkynylpyrimidine-based covalent inhibitor that targets a unique cysteine in NF-κB-inducing kinase (NIK) | 2021 |
|
Dr Christine Basmadjian
Dr Celine Cano
| Nek7 conformational flexibility and inhibitor binding probed through protein engineering of the R-spine | 2020 |
|
Dr Christine Basmadjian
| Flavaglines ameliorate experimental colitis and protect against intestinal epithelial cell apoptosis and mitochondrial dysfunction | 2016 |
|
Dr Christine Basmadjian
| Assessment of flavaglines as potential chikungunya virus entry inhibitors | 2015 |
|
Dr Christine Basmadjian
| Bioactive Flavaglines: Synthesis and Pharmacology | 2015 |
|
Dr Christine Basmadjian
| Exploratory studies toward a synthesis of flavaglines. A novel access to a highly substituted cyclopentenone intermediate | 2015 |
|
Dr Christine Basmadjian
| FL3, a synthetic flavagline and ligand of prohibitins, protects cardiomyocytes via STAT3 from doxorubicin toxicity | 2015 |
|
Dr Christine Basmadjian
| Flavaglines stimulate transient receptor potential melastatin type 6 (TRPM6) channel activity | 2015 |
|
Dr Christine Basmadjian
| Novel carbocationic rearrangements of 1-styrylpropargyl alcohols | 2015 |
|
Dr Christine Basmadjian
| Revision of the Synthesis and Pharmacological Activity of a Reported Translation Inhibitor | 2015 |
|
Dr Christine Basmadjian
| Cancer wars: natural products strike back | 2014 |
|
Dr Christine Basmadjian
| eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies | 2014 |
|
